Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia
Authors:
- Eustaquio J. ManosEMEustaquio J. Manos
- Ricardo I. MejaílRMRicardo I. Mejaíl
- Miguel A. CerdáMCMiguel A. Cerdá
- Ernesto A. DurontoEDErnesto A. Duronto
- Claudio N. GarcíaCGClaudio N. García
- Ana M. DarocaADAna M. Daroca
- Branco MautnerBMBranco Mautner
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Therapeutic approach to unstable angina: Nitroglycerin, heparin, and combined therapyAmerican Heart Journal, 1993
- A comparison of heparin strategies after thrombolytic therapyAmerican Heart Journal, 1993
- Comparison of High-Dose with Low-Dose Subcutaneous Heparin to Prevent Left Ventricular Mural Thrombosis in Patients with Acute Transmural Anterior Myocardial InfarctionNew England Journal of Medicine, 1989
- Aspirin, Heparin, or Both to Treat Acute Unstable AnginaNew England Journal of Medicine, 1988
- Low-Molecular-Weight HeparinNew England Journal of Medicine, 1986
- Silent Ischemia as a Marker for Early Unfavorable Outcomes in Patients with Unstable AnginaNew England Journal of Medicine, 1986
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart DiseaseNew England Journal of Medicine, 1981
- Coronary Vasospasm as a Possible Cause of Myocardial InfarctionNew England Journal of Medicine, 1978